FDA Approves Immunomedic’s Breast Cancer Treatment Trodelvy By Sam | April 23, 2020 The FDA previously granted the drug priority review, breakthrough therapy and fast- track designations. Source: Devices & Diagnostics Letter Posted in Devices & Diagnostics Letter